Verum

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Verum

Property Description
Active ingredient Betahistine dihydrochloride
Form Oral Tablets, Oral Solution
Pharmacological class Histamine Analogue, Anti-vertigo Agent
Common use Symptomatic relief of inner ear dysfunction
Origin Synthetic Compound

Verum is a prescription-only synthetic pharmaceutical preparation classified as an anti-vertigo agent and a Histamine Analogue. The active ingredient is Betahistine dihydrochloride, a molecule chemically derived to mimic the natural substance histamine. This classification places it under the Anatomical Therapeutic Chemical (ATC) code N07CA01 for antivertigo preparations. As a synthetic compound, its development allows for targeted modulation of specific neurological pathways. The drug is clinically recognized for its focused action, setting it apart from non-selective vestibular sedatives, as its primary focus is on stabilizing the inner ear. It is typically supplied for systemic administration in the form of oral tablets or, less commonly in some markets, as an oral solution.


Verum’s Composition and Purpose as a Monotherapy

Verum is a single-ingredient product or monotherapy, meaning its therapeutic function relies exclusively on the active substance, Betahistine dihydrochloride. This formulation, also recognized under various trade names globally, ensures a focused action primarily addressing the histaminergic system without the added complexity of combination products. The drug is presented as a solid form using standard pharmaceutical excipients to create the tablets suitable for stable, long-term therapeutic use. The general purpose of this synthetic compound is to address the underlying physiological disturbances in the inner ear by supporting microcirculation and vestibular compensation. The clinical benefit is associated with the improvement of inner ear blood flow and the enhancement of the brain's ability to process balance signals. The medication is designed to reduce the intensity and occurrence of spinning sensations and the lack of spatial awareness, often a primary complaint in patients experiencing vestibular dysfunction.

Regulatory References

  1. NIH MedlinePlus (Betahistine review)

What side effects are possible with Verum?

Possible Side Effects and Safety Information for Verum

This section details the adverse reactions and safety constraints for Verum as documented in official governmental regulatory sources (e.g., FDA, EMA). It is based on factual statements from the product's official safety profile.

Adverse Reaction Scope

The adverse event profile is formally classified by mathbffrequency and mathbfsystem affected, consistent with international regulatory standards.

Category Regulatory Standard
Frequency Classification Adverse reactions are assigned to defined categories: mathbfVery Common (ge 1/10), mathbfCommon (ge 1/100 to < 1/10), mathbfUncommon, mathbfRare, mathbfVery Rare, or mathbfFrequency Not Known.
Body System Classification Events are grouped by mathbfSystem Organ Class (SOC), such as Gastrointestinal Disorders, Nervous System Disorders, or Hepatobiliary Disorders.

Key Safety Information

  • Serious Adverse Reactions: The regulatory profile highlights specific, mathbfrare but clinically significant events such as severe hypersensitivity (e.g., anaphylaxis) or organ toxicity (e.g., severe hepatic injury). The frequencies for these events are explicitly documented in the official labeling.
  • Population-Specific Safety: Where data warrants, the label includes mathbfspecific safety statements for vulnerable groups, such as mathbfpediatric patients, mathbfolder adults, and individuals with mathbfrenal or hepatic impairment.
  • Time-Related Patterns: The product information notes adverse reactions that are mathbfmore common upon initiation of therapy or whose risk may mathbfincrease with duration of use, if these patterns were established during clinical development.
  • Safety Constraints and Monitoring: The official documents state mathbfsafety-derived limitations on use (e.g., specific conditions where use is cautioned or not recommended) and mathbfmandatory monitoring requirements (e.g., periodic EKGs or liver function tests) necessary for risk mitigation.

Connection to the Overall Safety Profile

The official safety information structures the understanding of Verum's risk by providing an objective, standardized list of mathbfwhat events have been reported and mathbfhow often they occur. By formally categorizing all risks and detailing specific constraints, the label defines the drug's established safety boundaries. This descriptive approach ensures the complete scope of risks, from common to serious, is documented and communicated as determined by government authorities.

Overdose and Emergency Response

Verum Overdose and When to Seek Help

Taking more than the prescribed dose of Verum can lead to an overdose, which requires immediate medical attention. An overdose is a serious medical emergency, and the symptoms can vary in severity and presentation depending on the amount taken and individual patient factors.

Signs of a Potential Overdose

If you or someone else has taken too much Verum, look for the following signs:

Symptom Category Potential Manifestation
Consciousness Extreme drowsiness, confusion, inability to wake up, or coma.
Respiration Slow, shallow, or stopped breathing; gurgling or choking sounds.
Circulation/Skin Slow or erratic heart rate, low blood pressure, pale or clammy skin, or blue-tinged lips/fingernails.
Other Seizures, vomiting, or loss of muscle tone (limp body).

When to Call for Emergency Help

Call your local emergency services immediately if any of the above signs are present or if an overdose is suspected, even if the person is awake. Do not wait for symptoms to worsen or attempt to treat the person yourself. If you have the medication container, keep it to show emergency personnel. It is crucial to be prepared to provide details about the drug, the quantity taken, and the time the dose was consumed. Follow the instructions provided by the emergency operator until medical help arrives.

Therapeutic Uses of Verum

What Verum Treats: Main Uses and Benefits

Verum (Paracetamol/Acetaminophen) is a widely used agent that is commonly used across domains where additional symptomatic support is needed. Its primary application may assist with providing supportive relief that helps ease the overall symptom burden related to physical discomfort and systemic imbalance. This active ingredient is commonly used to help with easing physical discomfort and contributes to managing high temperature.

This medicine is considered relevant in conditions characterized by periods of heightened symptoms, often used during phases when symptoms become more noticeable. It may assist with managing symptom clusters that may become intense or disruptive, such as common headaches, backaches, toothache, muscle pain, and symptoms that interfere with daily functioning, like those associated with colds or flu. The approach is relevant when short-term symptomatic assistance is appropriate.

“It supports patients during episodes of heightened discomfort and assists with maintaining functional stability when symptoms are more noticeable.”

It is applied in addressing symptoms related to systemic imbalance, such as high temperature, which supports general well-being during symptomatic phases. This benefit may help patients cope more steadily with symptom fluctuations.

Quick Fact: Support for Physical Discomfort and Systemic Imbalance

Eligibility and Restrictions for Use

Eligibility and Contraindications

Official government regulatory documents (such as those from the EMA or FDA) establish eligibility for drug use based on specific patient characteristics and clinical conditions. Use of this medicine is generally authorized for the adult population (18 years of age) unless specific exclusionary criteria are present.


Populations That Must Not Use Verum (Contraindications)

Classification Exclusionary Criteria
Hypersensitivity Known allergy or hypersensitivity to the active substance or any other component (excipient) of the medicine.
Physiological Status Pregnancy during the second and third trimesters; Lactation (use is not recommended).
Condition-Specific Severe Hepatic Impairment (severe liver disease).

Populations Requiring Special Consideration

  • Pediatric Use: Use in the pediatric population (children and adolescents under 18 years) is generally not recommended because safety and efficacy have not been fully established in this age group.
  • Renal Impairment: The drug is not recommended for patients with severe renal impairment (e.g., eGFR <15 mL/min/1.73 m^2) or those who are on dialysis.
  • Moderate Hepatic Impairment: Use is generally not recommended due to potential changes in drug metabolism.

Regulatory criteria mandate that the medicine be used only in the patient population for which the clinical benefit clearly outweighs the documented risk, specifically excluding those with absolute contraindications defined by serious co-existing conditions or documented hypersensitivity.

What should I know about interactions with other medicines?

Verum Interactions with Other Medicines and Products

This section summarizes officially documented interaction information for Verum (Betahistine dihydrochloride) based on regulatory prescribing documents. This information focuses solely on potential interactions as classified by government health authorities.


Documented Interaction Patterns

The regulatory profile identifies two main categories of medicines and products that may interact with Betahistine, requiring caution or consideration.

  • Monoamine-Oxidase Inhibitors (MAOIs): Caution is advised when Verum is co-administered with MAOIs (such as Selegiline). Regulatory data indicates that MAOIs can inhibit the metabolism of Betahistine, potentially increasing its systemic exposure. This is a pharmacokinetic concern related to the clearance of Verum.
  • Antihistamines ( H1-receptor antagonists): Since Verum is a histamine analogue, the concurrent use of Antihistamines may theoretically affect the efficacy of either medicine due to their shared target system.

Official Constraints and Other Product Interactions

Category Regulatory Status
Contraindicated Combinations None are formally listed solely due to interaction risk.
Food Intake Food slows the rate of absorption of Verum, but the total amount absorbed remains unchanged. No mandatory timing separation is required relative to meals.
Population-Specific Cautions No specific interaction-related dose adjustments are indicated for patients with hepatic or renal impairment based on current regulatory data.

The official interaction statements primarily establish a framework for caution regarding medicines that may alter Verum's clearance or overlap pharmacologically with its action.

Mechanism of Action

How Verum Works: Mechanism of Action

The action of Verum (Betahistine) relies on a specialized dual mechanism within the histaminergic system that operates across two distinct physiological domains: central nervous system (CNS) signaling and peripheral inner ear blood flow.


Modulation of Central Vestibular Compensation Rate

Verum's primary action is as an antagonist at the Histamine H₃ Receptors (H₃R), which function as presynaptic auto-receptors on nerve endings within the brainstem's vestibular nuclei. By blocking these receptors, Verum removes the inhibitory feedback that restricts the release of endogenous histamine and other neurotransmitters in the vestibular nuclei. This mechanism modulates neuronal activity within the vestibular nuclei and increases the rate of signal recalibration following asymmetric input from the inner ears

.


Influence on Inner Ear Microvascular Tone

Verum also acts as a partial agonist at the Histamine H₁ Receptors (H₁R), which are predominantly located on the vascular walls supplying the labyrinth. This activity induces localized vasodilation in the inner ear's minute blood vessels, augmenting blood flow to the stria vascularis. This peripheral mechanism influences fluid exchange dynamics, which affects the hydrostatic pressure maintained within the sensory organs .

Dosage and Administration Information

Verum is administered orally in the form of tablets, which are the approved dosage form for systemic use. The total daily dosage for adults generally ranges from 24 mg to 48 mg of betahistine dihydrochloride, given in divided doses throughout the day. Dosing should be individualized, with initial oral treatment often starting at 8 mg to 16 mg, taken three times daily (TID).

Administration and Timing

The total daily dose is typically administered in two (BID) or three (TID) separate doses. The tablets should be swallowed whole with water and are taken preferably with meals or immediately after food. This specific timing is recommended to help minimize or relieve potential mild gastric complaints. Treatment duration may be long-term, with improvement sometimes observed only after a few weeks, and the most favorable results potentially achieved after several months.

If a dose is forgotten, the instruction is to skip the missed dose and take the next dose at the usual scheduled time; a double dose should not be taken to make up for the forgotten one.

Use in Specific Populations

No dose adjustment appears necessary for older adults, or for patients with renal or hepatic impairment. Verum is not recommended for use in children and adolescents below the age of 18 due to insufficient data on its safety and efficacy in this population.

Recent Clinical Evidence

Research evidence / Overview of studies for Verum

Evidence for use in Ménière's Disease

Verum (Betahistine) was studied for its application in conditions characterized by fluctuating or episodic manifestations, specifically the recurrent vertigo, hearing issues, and tinnitus associated with Ménière's disease. The research base includes Randomized Controlled Trials (RCTs) and various Systematic Reviews that examined specific outcomes related to symptom change in adult populations with this diagnosis. Researchers primarily examined the frequency, duration, and severity of vertigo attacks, often requiring patient-reported diaries. Follow-up periods was observed in both short-term phases for acute changes and longer terms, sometimes up to a year, for evaluating attack management.

The findings describe patterns observed in the studies where some trials documented patterns observed in the measured attack frequency in the group receiving the study drug. However, the evidence quality varies across studies, and some large, high-quality trials reported mixed findings or no significant difference compared to placebo for key outcomes over long-term follow-up. Research highlights changes measured during the study period for vertigo severity, but the evidence concerning associated symptoms like hearing loss or tinnitus is limited and inconclusive.

Evidence for use in Vestibular Vertigo

Research also explored the use of Verum in the broader context of vestibular vertigo or vertigo of peripheral origin. These studies mostly involved double-blind, placebo-controlled trials applied in research contexts involving fluctuating or unstable symptoms. The trials examined the outcomes related to systemic or functional imbalance, such as the overall severity of the spinning sensation. Studies report how symptoms evolved in the observed populations, with some analyses suggesting an association between the study drug and changes observed in the perceived severity of vertigo.

Long-term Follow-up and Durability of Evidence

While some clinical trials was observed in populations for up to nine or twelve months, follow-up durations were limited in the broader body of evidence, especially for studies assessing consistent effects or long-term management of Ménière's disease. There is limited information for long-term outcomes that would clearly characterize the durability of any observed changes in symptom frequency. Research contributes to the broader evidence landscape by providing insight into short-term changes, but the long-term impact on the course of the condition is not fully established.

Gaps, Inconsistency, and Areas for Further Research

The body of research for Verum highlights several areas of remaining uncertainty. Evidence quality varies across studies, contributing to mixed findings regarding the measurements of the drug across different parameters. The findings describe group patterns, not personal outcomes, and the research is affected by the challenge of isolating observed patterns from the natural variability of episodic conditions. Subgroup findings are uncertain due to modest sample sizes and heterogeneous study designs.

Key Studies & References

  1. Betahistine for symptoms of vertigo - Cochrane Review
  2. Meta-analysis of clinical studies with betahistine in Meniere's disease and vestibular vertigo
  3. Betahistine in Ménière's Disease or Syndrome: A Systematic Review (2022)
  4. Public Assessment Reports of the Medicines Evaluation Board in the Netherlands (Example Regulatory Assessment)
  5. Betahistine or cinnarizine with or without dimenhydrinate for Ménière's disease/syndrome and symptoms of vestibular vertigo and/or tinnitus (Health Technology Assessment)

Frequently Asked Questions (FAQ)

Common questions about Verum (FAQ)


Q: How quickly does Verum typically start working?

A: Regulatory information indicates that the pharmacological effect on inner ear signals may begin within a few hours after taking the medicine. However, because the drug works to help stabilize the inner ear, clinical improvement in symptoms may be gradually observed after several weeks or even months of continuous use.


Q: What are the most commonly reported side effects of Verum?

A: Official documentation lists the most commonly reported side effects as headache, nausea, and dyspepsia. Dyspepsia is a general term for stomach discomfort or indigestion. The appearance of side effects is a factor to discuss with a healthcare professional.


Q: Do studies suggest Verum is more effective for some people than others?

A: Research documentation regarding the drug's effectiveness in specific patient subgroups is limited. The regulatory summary of evidence and findings regarding how the drug may affect specific populations differently are noted as being limited or inconclusive.


Q: Is it normal to feel tired when first starting Verum?

A: The official adverse event profile lists drowsiness, or somnolence, as a reported side effect. This event is classified as having a very rare frequency, as noted in the official regulatory documentation.


Q: What is the purpose of the different strengths (dosage options) of Verum?

A: Verum is available in a range of strengths to allow for individualized dosing plans. This process is described in official documents as a way to adjust the product to suit the patient’s clinical requirements.


Q: Why do doctors recommend taking Verum at a specific time of day?

A: Official documents recommend taking the tablets preferably with or immediately after meals. This specific administration timing is advised because it is intended to help minimize or relieve any potential mild gastric complaints, such as stomach upset.


Q: Are the reported side effects of Verum usually temporary?

A: According to official product information, the adverse effects reported are described as typically mild in nature. The effects are also described as generally resolving and not lasting for a long period of time.


Q: Does Verum carry a specific safety classification or warning from regulatory bodies (like an FDA Boxed Warning)?

A: The official labeling includes important safety statements, such as contraindications that exclude patients with conditions like Phaeochromocytoma. Cautions regarding use in patients with a history of peptic ulcers or bronchial asthma are also noted, and these factors are noted for consideration by a healthcare professional.


Q: Is Verum covered by the official label for more than one condition?

A: Official regulatory indications list the drug for the symptomatic relief of vertigo, tinnitus, hearing loss, and nausea. These symptoms are those observed in patients with Ménière's syndrome.


Q: Do food restrictions apply when taking Verum?

A: No specific food restrictions apply when taking this medicine. While taking the tablets with food is permitted and may help with stomach discomfort, official information states that the medicine can be taken with food, or separated from food, as regulatory documentation notes.


Q: Can Verum cause weight gain or weight loss?

A: Weight gain or loss is not listed among the commonly reported side effects in the official adverse reaction profile for the drug as a monotherapy. However, studies have examined the drug's effect on weight when it is co-administered with other medications, as described in research.


Q: Are there any common over-the-counter medicines that interact with Verum?

A: The official regulatory profile notes a theoretical risk of reduced efficacy when Verum is used at the same time as H₁-receptor antagonists. This class of medicines includes some commonly available over-the-counter allergy medications.


Q: Does Verum affect my ability to drive or operate machinery?

A: Official studies indicate that the medicine itself has no or negligible effect on the ability to drive or operate heavy machinery. However, the condition being treated, such as severe vertigo, may impair these abilities. Drowsiness has also been reported as a very rare side effect.


Q: Can I drink alcohol while using Verum?

A: Official regulatory sources describe that the consumption of alcohol is not contraindicated while taking this medicine.


Q: What if I take too much Verum by accident?

A: Documented cases of taking too much of the medicine have been associated with mild to moderate symptoms. These can include nausea, dry mouth, indigestion, and somnolence (drowsiness).


Q: How long does Verum stay in your system after stopping treatment?

A: The drug is rapidly absorbed and also eliminated quickly from the body. Pharmacokinetic data indicates that the terminal elimination half-life is approximately 3 to 4 hours.


Q: Are there any specific foods I should avoid while on Verum?

A: Official documents state that no specific foods are required to be avoided when taking this medication. While food may slightly slow the absorption rate, the total amount of medicine absorbed remains unchanged.


Q: Can Verum affect my blood pressure?

A: The official safety profile advises caution when treating patients who have severe hypotension, which is very low blood pressure. This factor is noted due to the drug's properties as a histamine analogue.


Q: Is Verum known to interact with herbal supplements?

A: Official regulatory sources note that insufficient data is available regarding the safety of combining the drug with herbal remedies and supplements. This limitation is due to the fact that these items are not tested under the same rigorous regulatory standards as prescription medicines.


Q: Can Verum cause changes in mood or behavior?

A: The official adverse reaction profile includes reports of mood or behavior changes, such as confusional state and hallucinations. These events are classified as very rare, as noted in the regulatory documents.


Q: Is Verum available as a generic medicine?

A: The active ingredient in Verum is Betahistine dihydrochloride. This is the general, non-proprietary chemical name for the active substance.


Q: What should I tell my dentist if I'm taking Verum?

A: The official safety profile advises caution regarding potential interactions with certain medicines, such as specific antihistamines. Additionally, the label notes cautions for patients with certain pre-existing conditions, such as a history of peptic ulcers or bronchial asthma.


Q: Can Verum be crushed or split?

A: The regulatory information on certain formulations notes that some tablets are manufactured with a score line. This means they are designed to facilitate division of the tablet.


Q: Does Verum affect sleep patterns?

A: The official adverse event reports list somnolence (drowsiness) as a very rare side effect associated with the medication.


Q: Why is Verum sometimes given with another medicine?

A: Official documentation describes the potential for pharmacokinetic and pharmacodynamic interactions when the drug is used at the same time as certain other medicines. These include Monoamine-Oxidase Inhibitors (MAOIs) and H₁-receptor antagonists (antihistamines).


Q: Does Verum impact fertility in men or women?

A: Pre-clinical animal studies did not indicate any effects on fertility in the study animals. Official regulatory documents have not established evidence to suggest that the drug reduces fertility in men or women.

How should Verum be stored and disposed of?

How to Store and Dispose of Verum

Verum (Acetaminophen/Paracetamol) must be stored strictly according to official regulatory labeling to ensure product stability and safety.

Required Storage Conditions

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Protection The product must be protected from moisture, excessive heat, and light.
Container Keep Verum in its original container and ensure the container is tightly closed.
Prohibited The medication must not be frozen and should not be stored in damp areas, such as a bathroom.
Child Safety Keep Verum out of the sight and reach of children at all times, as mandated by labeling.

Official Disposal Guidelines

Unused or expired Verum should be disposed of via a pharmaceutical drug take-back program. Disposal must not involve flushing the medicine down a toilet or pouring it into a drain unless specific government instructions authorize this. If a take-back program is unavailable, official guidelines recommend mixing the product with an unpalatable substance and sealing it before placing it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Verum found in:

A-Z Index: